These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37592781)

  • 21. CD8
    Zhang M; Ma J; Guo Q; Ding S; Wang Y; Pu H
    Front Immunol; 2022; 13():806877. PubMed ID: 35273597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the novel markers of PPAR signalling affecting immune microenvironment and immunotherapy response of lung adenocarcinoma patients.
    Zhang W; Liu J; Ren X; Zhang Z; Zhou M; Li Y; Wang J; Li Q; Zhu Q; Wu G
    J Cell Mol Med; 2024 Mar; 28(5):e17877. PubMed ID: 37556076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
    Chang W; Li H; Cheng Y; He H; Ou W; Wang SY
    Front Immunol; 2023; 14():1171145. PubMed ID: 37081889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and immunotherapeutic implications of bilirubin metabolism-associated genes in lung adenocarcinoma.
    Ren K; Ling X; Chen L; Li Z; Huang T
    J Cell Mol Med; 2024 May; 28(9):e18346. PubMed ID: 38693853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analyses.
    Liu Y; Zhang X; Pang Z; Wang Y; Zheng H; Wang G; Wang K; Du J
    Aging (Albany NY); 2024 May; 16(10):8772-8809. PubMed ID: 38771130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of PPP4C's impact on prognosis, immune microenvironment, and immunotherapy response in lung adenocarcinoma using single-cell sequencing and multi-omics.
    Wang K; Peng B; Xu R; Lu T; Chang X; Shen Z; Shi J; Li M; Wang C; Zhou X; Xu C; Chang H; Zhang L
    Front Immunol; 2024; 15():1416632. PubMed ID: 39026674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
    Sun Y; Ma Q; Chen Y; Liao D; Kong F
    Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Liu L; Wang C; Li S; Qu Y; Xue P; Ma Z; Zhang X; Bai H; Wang J
    Front Immunol; 2021; 12():677169. PubMed ID: 34354701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SFTPA1 is a potential prognostic biomarker correlated with immune cell infiltration and response to immunotherapy in lung adenocarcinoma.
    Yuan L; Wu X; Zhang L; Yang M; Wang X; Huang W; Pan H; Wu Y; Huang J; Liang W; Li J; Zhu X; Wang S; Guan J; Liu L
    Cancer Immunol Immunother; 2022 Feb; 71(2):399-415. PubMed ID: 34181042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated single-cell and bulk RNA-Seq analysis enhances prognostic accuracy of PD-1/PD-L1 immunotherapy response in lung adenocarcinoma through necroptotic anoikis gene signatures.
    Sui P; Liu X; Zhong C; Sha Z
    Sci Rep; 2024 May; 14(1):10873. PubMed ID: 38740918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A gene expression-based immune signature for lung adenocarcinoma prognosis.
    Wang L; Luo X; Cheng C; Amos CI; Cai G; Xiao F
    Cancer Immunol Immunother; 2020 Sep; 69(9):1881-1890. PubMed ID: 32372138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an immune-related genes signature in lung adenocarcinoma to predict survival and response to immune checkpoint inhibitors.
    Davoodi-Moghaddam Z; Jafari-Raddani F; Kordasti S; Bashash D
    J Egypt Natl Canc Inst; 2024 Oct; 36(1):30. PubMed ID: 39370456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel ADCC-related gene signature for predicting the prognosis and therapy response in lung adenocarcinoma.
    Zhang L; Zhang X; Guan M; Zeng J; Yu F; Lai F
    Inflamm Res; 2024 May; 73(5):841-866. PubMed ID: 38507067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma.
    Yu Q; Zhao L; Yan XX; Li Y; Chen XY; Hu XH; Bu Q; Lv XP
    World J Surg Oncol; 2022 Jun; 20(1):183. PubMed ID: 35668494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated bioinformatics analysis of nucleotide metabolism based molecular subtyping and biomarkers in lung adenocarcinoma.
    Luo D; Wang H; Zeng Z; Chen J; Wang H
    Front Immunol; 2024; 15():1430171. PubMed ID: 39148731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts.
    Ren Q; Zhang P; Lin H; Feng Y; Chi H; Zhang X; Xia Z; Cai H; Yu Y
    Front Immunol; 2023; 14():1201573. PubMed ID: 37325647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiomics Analysis of Disulfidptosis Patterns and Integrated Machine Learning to Predict Immunotherapy Response in Lung Adenocarcinoma.
    Liu J; Li H; Zhang N; Dong Q; Liang Z
    Curr Med Chem; 2024; 31(25):4034-4055. PubMed ID: 38685772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated bulk and single-cell RNA sequencing identifies an aneuploidy-based gene signature to predict sensitivity of lung adenocarcinoma to traditional chemotherapy drugs and patients' prognosis.
    Wang X; Chen J; Li C; Liu Y; Chen S; Lv F; Lan K; He W; Zhu H; Xu L; Ma K; Guo H
    PeerJ; 2024; 12():e17545. PubMed ID: 38938612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene signature based on B cell predicts clinical outcome of radiotherapy and immunotherapy for patients with lung adenocarcinoma.
    Han L; Shi H; Luo Y; Sun W; Li S; Zhang N; Jiang X; Gong Y; Xie C
    Cancer Med; 2020 Dec; 9(24):9581-9594. PubMed ID: 33098370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma.
    Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X
    J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.